Yumin Liu

Dr. Yumin Liu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
QCQi Cai
Qi Cai
HFHongliang Feng
Hongliang Feng
JHJing Huang
Jing Huang
MWMeiyao Wang
Meiyao Wang
QWQunfeng Wang
Qunfeng Wang
YLYumin Liu
Yumin Liu

1 March 2014 in Brain Research
Verified
Journal Article
Closed access
QCQi Cai
Qi Cai
CQChun-Yu Qiu
Chun-Yu Qiu
FQFang Qiu
Fang Qiu
TLTing-Ting Liu
Ting-Ting Liu
ZQZu-Wei Qu
Zu-Wei Qu
HHhubei university of science and 437100 and wang-ping hu
hubei university of science and 437100 and wang-ping hu

30 August 2022 in Nutritional Neuroscience
Verified
Journal Article
Closed access
YLYumin Liu
Yumin Liu
ZHZiqi Hu
Ziqi Hu
Jing WangJing Wang
Jing Wang
YLYanjun Liao
Yanjun Liao
LSLuan Shu
Luan Shu
Depression is one of the most common complications in patients with diabetes. Our previous study demonstrated puerarin, a dietary isoflavone, improved glucose homeostasis and β-cell regeneration in...

19 February 2022 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
MZMeng-Liu Zeng
Meng-Liu Zeng
JCJing-Jing Cheng
Jing-Jing Cheng
SKShuo Kong
Shuo Kong
XYXing-Liang Yang
Xing-Liang Yang
XJXiang-Lei Jia
Xiang-Lei Jia
BPBiwen Peng
Biwen Peng

1 September 2018 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
ZKZhaohong Kong
Zhaohong Kong
YHYan Hong
Yan Hong
JZJiang Zhu
Jiang Zhu
XCXin Cheng
Xin Cheng
YLYumin Liu
Yumin Liu

25 October 2023 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
SKShuo Kong
Shuo Kong
TCTao-Xiang Chen
Tao-Xiang Chen
XJXiang-Lei Jia
Xiang-Lei Jia
XCXue-Lei Cheng
Xue-Lei Cheng
MZMeng-Liu Zeng
Meng-Liu Zeng
BPBiwen Peng
Biwen Peng
Background: The astrocytes in the central nervous system (CNS) exhibit morphological and functional diversity in brain region-specific pattern. Functional alterations of reactive astrocytes are commonly present in human temporal lobe epilepsy (TLE) cases, meanwhile the neuroinflammation mediated by reactive astrocytes may advance the development of hippocampal epilepsy in animal models. Nuclear factor I-A (NFIA) may regulate astrocyte diversity in the adult brain. However, whether NFIA endows the astrocytes with regional specificity to be involved in epileptogenesis remains elusive. Methods: Here, we utilize an interference RNA targeting NFIA to explore the characteristics of NFIA expression and its role in astrocyte reactivity in a 4-aminopyridine (4-AP)-induced seizure model in vivo and in vitro. Combined with the employment of a HA-tagged plasmid overexpressing NFIA, we further investigate the precise mechanisms how NIFA facilitates epileptogenesis. Results: 4-AP-induced NFIA upregulation in hippocampal region is astrocyte-specific, and primarily promotes detrimental actions of reactive astrocyte. In line with this phenomenon, both NFIA and vanilloid transient receptor potential 4 (TRPV4) are upregulated in hippocampal astrocytes in human samples from the TLE surgical patients and mouse samples with intraperitoneal 4-AP. NFIA directly regulates mouse astrocytic TRPV4 expression while the quantity and the functional activity of TRPV4 are required for 4-AP-induced astrocyte reactivity and release of proinflammatory cytokines in the charge of NFIA upregulation. NFIA deficiency efficiently inhibits 4-AP-induced TRPV4 upregulation, weakens astrocytic calcium activity and specific astrocyte reactivity, thereby mitigating aberrant neuronal discharges and neuronal damage, and suppressing epileptic seizure. Conclusions: Our results uncover the critical role of NFIA in astrocyte reactivity and illustrate how epileptogenic brain injury initiates cell-specific signaling pathway to dictate the astrocyte responses.